This integrated cancer pathway describes the key mechanisms involved in the development of cancer containing the key prognostic markers and pathogenetic factors. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP1971 CPTAC Assay Portal] Oncogene Tumor supressor Oncogene Phosphorylated Phosphorylated cd5 b3b c38 dc7 20086245 PubMed microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010 Zhao JJ Lin J Lwin T Yang H Guo J Kong W Dessureault S Moscinski LC Rezania D Dalton WS Sotomayor E Tao J Cheng JQ 18591254 PubMed MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008 Gabriely G Wurdinger T Kesari S Esau CC Burchard J Linsley PS Krichevsky AM 21359530 PubMed miR-29b regulates migration of human breast cancer cells. Mol Cell Biochem 2011 Wang C Bian Z Wei D Zhang JG cancer pathway PW:0000605 Pathway Ontology 17681183 PubMed MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007 Meng F Henson R Wehbe-Janek H Ghoshal K Jacob ST Patel T cancer DOID:162 Disease